Menopause: unbalanced vaginal microbiota may promote inflammation
A study on menopausal women suggests that it may one day be possible to reduce inflammation of the vaginal mucosa by modulating the vaginal microbiota. Crucially, this could reduce the risk of infection and cervical cancer.
- Learn all about microbiota
- Microbiota and related conditions
- Act on your microbiota
- Publications
- About the Institute
Healthcare professionals section
Find here your dedicated sectionSources
This article is based on scientific information
About this article
At menopause, the vaginal microbiota may play a key role in women’s gynecological health.
Under normal circumstances, lactic acid bacteria called Lactobacillus, found in abundance in the vaginal flora, acidify the vaginal environment, helping to balance the microbiota.
45 to 55 the age at which the menopause transition most often begins ¹
87% of women experience at least one symptom in addition to the cessation of menstruation ²
20-25% suffer severe disorders affecting quality of life ²
How menopause modifies vaginal microbiota
During the premenopause (the period before menstruation ceases for good, see text box), the drop in estrogen levels leads to a reduction in the glycogen content of the mucosal cells, glycogen being the preferred food of Lactobacillus.
Less well nourished, Lactobacillus become less abundant and lose their dominant position in the flora, which can lead to imbalances in the vaginal microbiota ( (sidenote: Dysbiosis Generally defined as an alteration in the composition and function of the microbiota caused by a combination of environmental and individual-specific factors. Levy M, Kolodziejczyk AA, Thaiss CA, et al. Dysbiosis and the immune system. Nat Rev Immunol. 2017;17(4):219-232. ) ). The reduction in sex hormones is also associated with a harmful increase in microbial diversity.
55% of women are aware that from childhood to menopause, a woman's vaginal microbiota does not remain the same.
Several studies have shown that the loss of Lactobacillus dominance and the increase in bacterial diversity are associated with inflammation of the vaginal mucosa. Inflammation increases the risk of infection, particularly with sexually transmitted infections (STIs), and of precancerous cervical lesions.
While the link between changes in the vaginal microbiota and inflammation has been shown in premenopausal women, no study has yet been carried out to determine whether it persists in the postmenopausal period (see text box).
Menopause, premenopause, postmenopause, or perimenopause: what’s the difference?
The menopausal transition, characterized by the gradual decline in female sex hormones, takes place over a number of years.
- The premenopause (or perimenopause) is the pivotal period prior to menopause. It precedes the cessation of menstruation, when the infamous symptoms of menopause appear (hot flushes, vaginal dryness, sleep disorders, etc.). It lasts from two to eight years, or around four years on average.
- Menopause is the final cessation of menstruation. It generally occurs between the ages of 45 and 55.
- Postmenopause is the period following menopause. It starts about one year after menopause.
Modulating the vaginal microbiota to preserve health?
To document this, a team of US researchers used data from 119 postmenopausal women (average age 61) who had taken part in a clinical trial comparing the effects of estrogen or a moisturizing cream on the vaginal flora.
They analyzed both bacterial populations and markers of inflammation (cytokines) in the volunteers’ vaginal fluids to determine whether these two parameters were linked. 3
They found that the women whose vaginal microbiota was the most diverse, or the most depleted in Lactobacillus, had the highest levels of cytokines. These two characteristics of the vaginal microbiota are therefore associated with inflammation, as in premenopausal women.
The vaginal microbiota
These results are interesting, since they suggest that it may one day be possible, by modulating the vaginal microbiota of postmenopausal women, to limit inflammation of the vaginal mucosa, and thus act preventively to preserve their health.
What is genitourinary syndrome of menopause (GSM)?
Since 2014, this term has replaced “vulvovaginal atrophy” or the overly restrictive “vaginal dryness”, and is used to describe specific menopausal symptoms linked to the drop in estrogen levels occurring at menopause 4 :
- Genital symptoms: dryness, burning, and irritation;
- Sexual symptoms: lack of lubrication, discomfort, and pain;
- Urinary symptoms: urinary urgency, recurrent urinary tract infections, pain, discomfort, and burning when urinating (dysuria)
According to a meta-analysis published in 2022 5, GSM affects:
- more than half of postmenopausal women (55.1%);
- one-third of perimenopausal women (31.9%);
- one in five premenopausal women (19.2%).